BRIEF-Teradyne Q4 Adjusted EPS USD 0.95 Vs. IBES Estimate USD 0.91

Reuters
30 Jan
BRIEF-Teradyne Q4 Adjusted EPS USD 0.95 Vs. IBES Estimate USD 0.91

Jan 29 (Reuters) - Teradyne Q4 revenue USD 753 million vs. IBES estimate USD 740.8 million.

  • Q4 EPS USD 0.9
  • Q4 net income USD 146.3 million
  • Q4 adjusted net income USD 155 million vs. IBES estimate USD 148.1 million
  • outlook Q1 revenue USD 660-700 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10